文献
J-GLOBAL ID:202102260250438670
整理番号:21A1446795
症例報告:再発性および転移性RAIR-DTCを有する患者におけるアンロチニブ治療は共存性TERTプロモーターおよびBRAF→V600E変異を有する【JST・京大機械翻訳】
Case Report: Anlotinib Therapy in a Patient With Recurrent and Metastatic RAIR-DTC Harboring Coexistent TERT Promoter and BRAFV600E Mutations
著者 (9件):
Su Yanjun
(Department of Thyroid Surgery, The First Affiliated Hospital of Kunming Medical University, Kunming, China)
,
Cheng Shaohao
(Department of Thyroid Surgery, The First Affiliated Hospital of Kunming Medical University, Kunming, China)
,
Qian Jun
(Department of Thyroid Surgery, The First Affiliated Hospital of Kunming Medical University, Kunming, China)
,
Zhang Min
(Department of Thyroid Surgery, The First Affiliated Hospital of Kunming Medical University, Kunming, China)
,
Li Tuanli
(Department of Thyroid Surgery, The First Affiliated Hospital of Kunming Medical University, Kunming, China)
,
Zhang Ying
(Department of Thyroid Surgery, The First Affiliated Hospital of Kunming Medical University, Kunming, China)
,
Diao Chang
(Department of Thyroid Surgery, The First Affiliated Hospital of Kunming Medical University, Kunming, China)
,
Zhang Ling
(Department of Thyroid Surgery, The First Affiliated Hospital of Kunming Medical University, Kunming, China)
,
Cheng Ruochuan
(Department of Thyroid Surgery, The First Affiliated Hospital of Kunming Medical University, Kunming, China)
資料名:
Frontiers in Oncology (Web)
(Frontiers in Oncology (Web))
巻:
11
ページ:
626076
発行年:
2021年
JST資料番号:
U7089A
ISSN:
2234-943X
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
スイス (CHE)
言語:
英語 (EN)